A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to U. S. researchers. Their research was presented at the American Thoracic Society 2013 International Conference and published simultaneously online in the New England Journal of Medicine...
More...
More...